Skip to content
DefDex

Federal award

HADAL, INC

N0001416C3020

Contract

Obligated and Ceiling

Obligated (net)
$3,491,359.57
Ceiling (potential value, not spending)
$6,493,777.00
Current value
$4,976,276.00
Gross positive obligations
$3,514,025.00

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
HADAL, INC · JDUMMWFY9L74
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
HADAL INC · TKJVBMBHFDA2
Awarding agency
Department of War · sub-agency 1700 · office N00014
Funding agency
Department of War · sub-agency 1700
Product or service (PSC)
AD91 · R&D- DEFENSE OTHER: OTHER (BASIC RESEARCH)
Industry (NAICS)
541712 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)
PIID
N0001416C3020
Award type code
D
Actions
15 · Dec 28, 2015 to Jun 30, 2026
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History15

Award actions
DateFYModAction typeObligationCompany in company totals
Jun 30, 2026FY2026P00014C−$22,665.43
—
Feb 27, 2020FY2020P00013C$132,027.00
—
Feb 11, 2020FY2020P00012C$592,973.00
—
Dec 11, 2019FY2020P00011C$75,000.00
—
Mar 29, 2019FY2019P00010M$0.00
—
Jan 22, 2019FY2019P00009C$131,025.00
—
May 16, 2018FY2018P00008C$285,122.00
—
Apr 20, 2018FY2018P00007C$234,878.00
—
Mar 28, 2018FY2018P00006C$50,000.00
—
Mar 1, 2017FY2017P00005C$500,000.00
—
Dec 8, 2016FY2017P00004C$500,000.00
—
Aug 9, 2016FY2016P00003C$300,000.00
—
May 9, 2016FY2016P00002C$513,000.00
—
Mar 4, 2016FY2016P00001M$0.00
—
Dec 28, 2015FY20160—$200,000.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.